TuHURA Biosciences, Inc. HURA
2.10
0.00
0.00%
as of 25 Sep
- Market cap
- $133.8M
- P/E
- 0.0×
Follow HURA
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
0.40 | 0.78 | 1.15 | 0.18 |
Net Debt/EBITDA |
0.40 | 0.47 | 0.84 | (0.92) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 27.63% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.47 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.56 | 0.82 | 0.59 | 0.94 | |
Capex/Depreciation |
(59.12) | 2.44 | (2.08) | (0.42) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.53 | 0.39 | 0.36 | 0.34 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.24) | (0.09) | (0.07) | (0.14) | |
Cash per Share |
0.05 | 0.08 | 0.11 | 0.02 | |
Shareholders Equity per Share |
0.33 | 0.44 | 0.39 | 0.29 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.33 | 0.44 | 0.39 | 0.29 | |
Free Cash Flow |
(12.35) | (4.32) | (4.46) | (8.77) | |
Working Capital |
(5.33) | (1.30) | 0.92 | (7.60) | |
Capital Expenditures |
(1.26) | 1.23 | (0.05) | (0.14) | |
Net Current Asset Value |
(5.42) | (1.80) | 0.47 | (11.59) | |
| Other line items | |||||
Quick Ratio |
0.31 | 0.70 | 1.04 | 0.11 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.22) | (0.12) | (0.07) | (0.13) | |
Capex per Share |
(0.02) | 0.03 | 0.00 | 0.00 | |
Average Receivables |
— | 0.25 | — | — | |
Average Payables |
3.84 | 5.45 | 5.24 | 7.98 | |
Average Assets |
14.92 | 23.66 | 22.17 | 33.18 | |
Average Common Equity |
8.96 | 17.48 | 16.24 | 18.70 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates